Ledger.

Managing Director, Ziff Capital Partners

Dr Steven M. Altschuler

Coverage

Stories naming Dr Steven M. Altschuler. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Exit / M&A

Azura Ophthalmics Appoints Biopharma Industry Veteran Steven Altschuler, M.D. as Chair of the Board

Eye-disease drug developer Azura Ophthalmics has appointed healthcare biotech veteran Steven Altschuler, a Ziff Capital Partners managing director and Spark Therapeutics co-founder, as chair of its board.

Brandon BioCatalyst portfolio Tue 7 Sep 2021 89BioAffinivaxAsclepiX TherapeuticsAzura OphthalmicsBrigham and Women's Physician OrganizationChildren's Hospital of PhiladelphiaImVaxOrchardPlateletBioRoche GroupSpark TherapeuticsUniversity of Miami Health SystemWWZiff Capital PartnersAshwin AgarwalMarc GleesonDr Steven M. Altschuler

Also Brandon Capital portfolio

Something wrong? Tell us